{"name":"Tizona Therapeutics, Inc","slug":"tizona-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"globenewswire.com","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - globenewswire.com","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPSlFhcVdwaFlONm5LenM3akJpY2hmc04zT3hMeWFVMm50ZTBMTWNZNlFWRFBUOUdJZ010blhQNkpKR1gzd2NwN0lDOXFRQlFQVmZZSW82aDRiYU94a3VaZDkxWWsxTWJGUEJlNnJWa1pGV2FEZkFLX3QyVWJJSDQ2ajgxZnVQY25wZnloZ3RBOVR4RGhSZ1REYjhHWGhzeTlmVjFmbEQ5b1ZSTktKQzltVDM0bHdBNm1DSEM2S1VSbEl0a0QybjUzZE5laFF2YTFqSkZNYlVrdXBKQm9lVjlZTTZiSDMwa3YzMUgwaHAxeV82LVNKZTFoZUI5ZG1NbThqUlE5bEFBUWJ6Rm5XcVV5Q2VWNl9NREdCN2lycUhOU2otUEh6NDBmSERtS3VPaENoMnI3M0tKRmxmTjg?oc=5","date":"2025-05-13","type":"trial","source":"globenewswire.com","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline - globenewswire.com","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOOEloNzBMUVo2VDlxYlpXM2NsZWh0Zmgyb0dZc2dWaXJNUm9adUtqNmdKaWVIWGZnbFJrdWE3bHhZeFlMYkZfc1lpb0N3TXVRQXExTUJaQUZFWFdOTlJOQjhsYkpBM2piWEhJazBwRlpKaUs2YzN0LWFyLW1OUFFSREpRM1IzbklTVkU0Y2RSUHB6TTdnNG0zUGZMVHNnWHhhVlZMRXdwNklETXVwY0tSQ2J3am82VmpRQ2dRX2d6WHh0cGg0TGR4ZEVTb1JGYXNKX2I4S0xBcDFsSWRla1JmaXEzdHdGTVlPcXVXSXJWekRLdUNzQk1VS1YzMVVQVjE2eFZLQjB6Y2JhWFZTbWZXN2l5OFRlOEYxZ3o2ZHFHMkJuMUdZM0ltX3NJRTJSNWVZTWUybThENGFlSWh4ZWc?oc=5","date":"2025-04-23","type":"pipeline","source":"PR Newswire","summary":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - PR Newswire","headline":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNenh2T2dGNlRQekh5NjRkdnVpRXVDUC1Dams3WWU2OU5qU0dkZTJNOTFRR204VTZYS3oxaGp4UVdodmoxVjByZ3c3SUtvaDM1OWlkRGJTeWgwS2dTNGV0dUlFcWZETlVDS00tenE2YlItaklTLUxPaHRnalZaTzdGN1JFUGQyVy1jeHFKZjV2YzlRQnpkUEcyV0RzLVM4cVdUZ1NuNg?oc=5","date":"2025-02-28","type":"trial","source":"Endpoints News","summary":"Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves - Endpoints News","headline":"Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNdlcyRzc0UWU5ZHpXLUdsd1BFcFpKTkRuTl9xQkNoQVozR3ZTVkszMU1OdWJqb0ptR05TNHJfbFZaVFBxUlkyWkM5Sm96S1psbXNoVzlyeXRUM2FRMG53TGhVRHlna1B6c2x2UU93QzVySFA3UWJnX3pJYkRWNWRDeUI3UjVXZGdRbVRiV01RcmNrLURjVTYyWEp3dlpDUFBTaGh4aTR4dGdDbUQ0czhFNHhadnRleXRXOEdSRFBkOA?oc=5","date":"2024-06-04","type":"pipeline","source":"Healio","summary":"Durvalumab extends survival in limited-stage small-cell lung cancer - Healio","headline":"Durvalumab extends survival in limited-stage small-cell lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPZ3dDRTEyaHlxaGo5SW1YQlNkS2FTazBycnpaVnNrcy1ENmpyTm9uc1FtSU95SFVjUlZKSVpjVlhzb3VScmRiVF9iX3IzZXVWUjVLcW1SdzNLRC0yUFhHQnB3aFFhWHI5VjYyWnM2M0N2eVJ3b2Q2XzR3RHpLbENkTWNmcmtsMnJkZUF5NWFqZUVoTTcxdS1sdEl0U3RrYU05VE5NT3JIRmJUOE5lRjcwYTNFZ0hvQUxxc2JnYzBnNjN1dG4z?oc=5","date":"2024-02-07","type":"trial","source":"Fierce Pharma","summary":"Gilead undeterred in oncology despite CAR-T growth slowdown, Trodelvy trial miss - Fierce Pharma","headline":"Gilead undeterred in oncology despite CAR-T growth slowdown, Trodelvy trial miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQd3BWTXJrNmRvenQ4Y0VzMnFUMnRnZnoxQ1kxWVVvei1ILUhoNDVyanBvSWJrUTVxd25kN0tJTS10YUxrYWpXYlhaUjdtUzNMT0dCTHJwbXZmc0JleHlhWEMyOFVJVzM4NU04b1Zvd3drRHlEUXNrckhXdWVjd2tab3drUGdoclg0LUY2UW5qRGtsZTdlM2lrb05B?oc=5","date":"2024-02-06","type":"deal","source":"Fierce Biotech","summary":"Gilead will not buy Tizona after paying $300M for the right to do so - Fierce Biotech","headline":"Gilead will not buy Tizona after paying $300M for the right to do so","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPSThQS3BfdXN5dlBFakwxTk91andTR05BQ3R3TjVWeFA2dERtWmE1dVlIM0pFM3hDX1pMZDNOcDQxc01Qak0yQm5DXzJTTHJ0MUloaXB0SDZ2V2hqZ2xfeVhFNzdMUlNPWU9ZQ2ZKMXVVemlIYld5c2ZLOU04MHhCSUFrVDUzaVFoY3ljbk9WTUNLZw?oc=5","date":"2023-11-02","type":"deal","source":"Hunt Scanlon Media","summary":"Slone Partners Fills Board Positions for Fusion Pharmaceuticals - Hunt Scanlon Media","headline":"Slone Partners Fills Board Positions for Fusion Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPT3Z0XzU0Rll4Yl9penFGYnl4Y0ZhZFFQdElvZUdaSVpNSFN0QlFHMENDalhPejgxampRNUtBWWJ1ekpEQWNyMjQ2dzRRSVVyMVFWOVg4Rk9tZXlPRTBiZUNOM2lWMy0ydWdpdG9hSFJINUhzblcxcGdSZWNhUC1JSUV0dVdMMnhTX3AtQ0Ywc0FYNWJqMnlZN2wzajd4MVMwVWNiNjEwRnE1UTdLODVWNGZJMlRLbEYzSEtud3hTcllNZ0F4UUlpUTRRYnlhVFFtbHFmOFMxdkYweHo1QzVJVjhZaDdfU19XcTNGaWM2UGo5SGtFcGEtV2hETVBCUVJadUJLdUtoaWtZSXdJWW5nWUxwQmVZdw?oc=5","date":"2023-10-16","type":"pipeline","source":"PR Newswire","summary":"Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors - PR Newswire","headline":"Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1Mb0txMXlPcFlHUWV5dFEyUEJVWW9QdWc0WG1vcUdfVWM5QWZuLUh4ZGhNdDEtcDFCT05RNHhaNTNuVjhGSmQ3QmV1cVZITU1aVE5R?oc=5","date":"2023-07-24","type":"deal","source":"Lightspeed Venture Partners","summary":"Dr. Shelley Chu - Lightspeed Venture Partners","headline":"Dr. Shelley Chu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQN0RIQnYtbFQtMlpldnR6bjRkcXhYaUNTU0FyeTl1SkVmRzREMUVMWFhBMXE0cHdxQVp0UmFnWlplYmtuZWU1Y1Y1WEFtNEF2ckdKWHYwY3FVdmFaSXhiZ2tZUTdHYWpxVmQtb0hjeFFqckVySklLT1hmbDkxUnVVVEhVdHFycVpENUVIQTZ0elY0UDBpRHVxT2FCaldEWVJV?oc=5","date":"2019-11-20","type":"pipeline","source":"ASCO Daily News","summary":"Insights Into the Role of Immune Checkpoint Inhibitors in Colorectal Cancer - ASCO Daily News","headline":"Insights Into the Role of Immune Checkpoint Inhibitors in Colorectal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE81eXBaakI2X2RHTXBCcExXR1QxaGxKUmd2YUZjRzBaQ25FZXdDc0lOYWV4TVJKZXExLXBLR3hldzI3cnB4TmsyVkN3MHp3TC05TXBsQmxVZ21HdEkzNEp5NE9n?oc=5","date":"2019-10-14","type":"pipeline","source":"PharmaLive","summary":"AbbVie 2019: After Humira - PharmaLive","headline":"AbbVie 2019: After Humira","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}